• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Oxibendazole

Oxibendazole

Product ID O9334
Cas No. 20559-55-1
Purity ≥98%
Product Unit SizeCostQuantityStock
5 g $122.00 In stock
10 g $209.00 In stock
25 g $434.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Oxibendazole is a benzimidazole antifungal compound that also exhibits anti-parasitic and anti-helminthic activities. This compound inhibits microtubule polymerization. Oxibendazole is used in veterinary medicine, displaying efficacy against species of Coronocyclus, Cylicocyclus, Cyathostornum, Cylicostephanus, Strongylus, and Oxyuris.

Product Info

Cas No.

20559-55-1

Purity

≥98%

Formula

C12H15N3O3

Formula Wt.

249.27

Chemical Name

(5-propoxy-1H-benzimidazol-2-yl) carbamic acid methyl ester

IUPAC Name

methyl N-(6-propoxy-1H-benzimidazol-2-yl)carbamate

Synonym

Equitac, SKF-30310, Anthelcide EQ

Melting Point

230-230.5°C

Solubility

Insoluble in water. Soluble in acetic acid and formic acid.

Appearance

White or almost white crystalline powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

O9334 MSDS PDF

Info Sheet

O9334 Info Sheet PDF

References

Nielsen MK, Betancourt A, Lyons ET, et al. Characterization of the inflammatory response to anthelmintic treatment of ponies with cyathostominosis. Vet J. 2013 Nov;198(2):457-62. PMID: 24035469.

Traversa D, Iorio R, Otranto D, et al. Species-specific identification of equine cyathostomes resistant to fenbendazole and susceptible to oxibendazole and moxidectin by macroarray probing. Exp Parasitol. 2009 Jan;121(1):92-5. PMID: 18950625.

Kates KC, Colglazier ML, Enzie FD. Oxibendazole: critical anthelmintic trials in equids. Vet Rec. 1975 Dec 6;97(23):442-4. PMID: 1216434.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C4758

    Closantel Sodium

    Protonophore; chitinase OvCHT1 inhibitor.

    ≥98%
  • C0153

    Calcitonin, rat

    Endogenous neuropeptide hormone, lowers extrace...

    ≥95%
  • Z4900

    ZM-447439 Trihydrate

    AurKA/B inhibitor.

    ≥99%
  • V1870

    Verruculogen

    Mycotoxin produced by Aspergillus; BK K+ channe...

    ≥95%
  • D3262

    Dipropyl Sulfide

    Organosulfide found in Allium; cholesterol synt...

    ≥99%
  • C0150

    Camptothecin

    Quinolone alkaloid precursor of irinotecan, ori...

    ≥98%
  • N3350

    Nimorazole

    Nitroimidazole; hypoxic modifier and radiosensi...

    ≥98%
  • K0088

    Kawain

    Kavalactone originally found in Piper methystic...

    ≥98%
  • A0917

    1′-S-1′-Acetoxychavicol Acetate

    TRPA1 agonist, xanthine oxidase inhibitor.

    ≥98%
  • M5756

    Montelukast Sodium

    CysLT1 antagonist.

    ≥98%
  • I4000

    Ikarugamycin

    Protein translation inhibitor.

    ≥98%
  • P6818

    Prednisolone

    Cortisol derivative; glucocorticoid agonist.

    ≥98%
  • V1745

    Veliparib

    PARP inhibitor.

    ≥99%
  • T1002

    2-Debenzoyl Paclitaxel-2-(2-Methyl-2-Butenoate)

    Synthesis intermediate

    ≥95%
  • S3476

    Sitagliptin Phosphate Monohydrate

    DPP4 inhibitor.

    ≥98%
  • E6256

    Epothilone A

    Microtubule depolymerization inhibitor.

    ≥95%
  • I0417

    R-(−)-Iberin

    Sulforaphane homolog, ITC found in cruciferous ...

    ≥98%
  • A5061

    Ampalex

    Benzylpiperidine; AMPA potentiator.

    ≥98%
  • C324091

    Ciclesonide

    Corticosteroid

    ≥98%
  • G733409

    GSK-2982772

    RIP1 inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only